Island Hospital is participating in Ikaria’s PRESERVATION I clinical trial.
PRESERVATION I is a multi-national, placebo-controlled trial investigating the
safety and efficacy of the Bioabsorbable Cardiac Matrix device, or BCM, which
is being developed for the prevention of ventricular remodeling and subsequent
congestive heart failure following acute myocardial infarction (heart attack).
There are currently no FDA-approved treatments to prevent cardiac remodeling
following a heart attack. For more information about this trial, visit www.clinicaltrials.gov.